CLINICAL_TRIALS
withdrawal
· 2015-09-23
Clinical Trial Update: Relevance of Flavanols for Cardiovascular Function in End-Stage Renal Disease [Phase 2]
Summary
Phase 2 study evaluating flavanols for cardiovascular function in end-stage renal disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: RWTH Aachen University | Conditions: End Stage Renal Disease | Phase 2 | Status: WITHDRAWN